FDA Clearance Tracker · P960043-S124
Perclose ProGlide® Suture-Mediated Closure System, Prostar® XL Percutaneous Vascular Surgical System
Last checked: Nov 20, 2026Latest source record: Feb 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 10, 2025
Approved
Time to decision
157 days
Received Sep 6, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P960043-S124
- Device name
- Perclose ProGlide® Suture-Mediated Closure System, Prostar® XL Percutaneous Vascular Surgical System
- Applicant
- Abbott Vascular, Inc.
- Applicant location
- Redwood, CA
- Received
- Sep 6, 2024
- Decided
- Feb 10, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P960043
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
approval for a manufacturing site located at Centerpiece S. de. R.L. de C.V., Bulevar La Encantada Industrial, Parque Industrial El Florido, Seccion La Encantada 11530, Tijuana, Baja California, 22250, Mexico for sterilization.
Source documents
Other decisions for Abbott Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XACT Carotid Stent SystemPMA supplement
P040038-S043 · Decided Feb 7, 2024 · 225 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.